Background: Caffeic acid is industrially recognized for its antioxidant activity and 12 therefore its potential to be used as an anti-inflammatory, anticancer, antiviral, 13 antidiabetic and antidepressive agent. It is traditionally isolated from lignified plant 14 material under energy-intensive and harsh chemical extraction conditions. However, 15 over the last decade bottom-up biosynthesis approaches in microbial cell factories have 16 been established, that have the potential to allow for a more tailored and sustainable 17 production. One of these approaches has been implemented in Escherichia coli and 18 only requires a two-step conversion of supplemented L-tyrosine by the actions of a 19 tyrosine ammonia lyase and a bacterial Cytochrome P450 monooxygenase. Although 20 the feeding of intermediates demonstrated the great potential of this combination of 21 heterologous enzymes compared to others, no de novo synthesis of caffeic acid from 22 strategy that rendered even an initially unproductive Cytochrome P450/ redox system 33 combination productive. 34
glucose has been achieved utilizing the bacterial Cytochrome P450 thus far. 23 Results: The herein described work aimed at improving the efficiency of this two-step 24 conversion in order to establish de novo caffeic acid formation from glucose. We 25 implemented alternative tyrosine ammonia lyases that were reported to display superior 26 substrate binding affinity and selectivity, and increased the efficiency of the Cytochrome 27 P450 by altering the electron-donating redox system. With this strategy we were able to 28 achieve final titers of more than 300 µM or 47 mg/L caffeic acid over 96 h in an 29 otherwise wild type E. coli MG1655(DE3) strain with glucose as the only carbon source. 30
We observed that the choice and gene dose of the redox system strongly influenced the 31 Cytochrome P450 catalysis. In addition, we were successful in applying a tethering 32 from primary metabolism by a phenylalanine ammonia lyase associated with the 48 endoplasmatic reticulum and transformed into trans-cinnamic acid. Cinnamic acid is 49 then hydroxylated by the membrane-anchored Cytochrome P450 enzymes cinnamate 50 4-hydroxylase (C4H) and p-coumarate 3-hydroxylase to p-coumarate and caffeic acid, 51 respectively [7, 8] . From there a range of molecules can be produced that serve as 52 lignin building blocks or precursors for secondary metabolites such as tannins, 53 (iso)flavonoids, anthocyanins, stilbenes and coumarins [9] . All of these compounds 54 have high market value but are difficult to isolate because they are of low natural 55 abundance (e.g. stilbenes and coumarins), or challenging to extract (e.g. lignin-derived 56 aromatics) [10] . Therefore, over the last decade various strategies have been 57 developed to implement biosynthetic pathways in microbial cell factories that promise 58 their tailored biosynthesis in a sustainable manner. Recent examples are the production 59 of stilbenoids and flavonoids in Corynebacterium glutamicum [11, 12] , and curcumin 60 [13, 14] and caffeic acid [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] in Escherichia coli. For the biosynthesis of p-coumaric 61 acid in E. coli, it was found that using L-tyrosine as a pathway precursor was superior 62 over phenylalanine [25] , since activity of the plant Cytochrome P450 enzyme C4H could 63 not be reconstituted as of recently [26] . Based on this finding, two major strategies have 64 been devised to produce caffeic acid that employ microbial tyrosine ammonia lyases 65 (TAL) to generate p-coumaric acid followed by either (1) a flavin-dependent HpaBC-type 66 oxidoreductase complex (4-hydroxyphenylacetate 3-hydroxylase, PFAM PF03241) from 67
Saccharothrix espanaensis [14-18], E. coli [19] [20] [21] , Thermus thermophilus HB8 [20] or 68
Pseudomonas aeruginosa [22, 23] , or (2) a bacterial cytochrome P450 enzyme 69 CYP199A2 F185L from Rhodopseudomonas palustris [14, 18, 24] . In all of these 70 studies it became evident that the caffeic titers are rather low unless L-tyrosine or p-71 coumaric acid are added to the growth media, or the aromatic amino acid pathway is 72 engineered to increase intracellular L-tyrosine levels. For the pathways utilizing HpaBC-73 type oxidoreductases, the highest titer reported for de novo synthesis in wild-type E. coli 74 to date is 42 mg/L (S. espanaensis TAL and HpaBC) [17] . However, to our knowledge 75 no de novo synthesis has been reported for pathways utilizing CYP199A2 F185L. 76
In this study, we established de novo biosynthesis of caffeic acid from glucose through 77 the actions of TAL and CYP199A2 F185L NΔ7. In order to achieve this goal, we tested 78 CYP199A2 F185L NΔ7. We found that driving the binding equilibrium of the electron-80 donating redox partners to CYP199A2 F185L NΔ7 towards the bound state improves 81 pathway titers and enabled us to produce ~47 mg/L caffeic acid from glucose in wildtype 82 E. coli MG1655(DE3). This titer is slightly higher than the titers reported for the HpaBC-83 based pathways in wildtype E. coli with glucose as the only carbon source [17, 19] . 84
Results

85
In an earlier study Rodrigues et al. demonstrated the two-step conversion of 3 mM L-86 tyrosine to caffeic acid in E. coli MG1655(DE3) expressing the enzymes RgTAL and 87 CYP199A2 F185L NΔ7 with redox partners, without reporting de novo production of 88 caffeic acid from glucose ( Figure 1) [18]. In this study we set out to improve these 89 enzymatic steps to establish caffeic acid production from glucose without supplementing 90 L-tyrosine. When examining the two-step conversion more closely, we determined that 91 both pathway steps needed improvement. First, the efficiency of the committed step, the 92 conversion of L-tyrosine to p-coumaric acid, determines how much L-tyrosine is 93 withdrawn from primary metabolism and fed into the pathway. Therefore, we 94 hypothesized that TAL variants with higher selectivity and affinity for L-tyrosine would 95 improve pathway flux. Second, the hydroxylation of p-coumaric acid to caffeic acid 96 catalyzed by CYP199A2 F185L NΔ7 appears to be a bottleneck in the pathway, since p-97 coumaric acid accumulates in the fermentation [18] . This accumulation is thought to be 98 detrimental because p-coumaric acid has been shown to inhibit TAL activity and to be 99 cytotoxic [27, 28] . Since a common problem with Cytochrome P450 catalyzed reactions 100 is the protein-protein interaction with redox partners, which is strictly required for 6 electron transfer and substrate turnover [29], we hypothesized that driving the assembly 102 of the redox complex would lead to higher product titers. 103
To improve the first pathway step, we selected two homologous tyrosine ammonia 104 lyases with supposedly superior characteristics compared to RgTAL, namely a stronger 105 selectivity for L-tyrosine over L-phenylalanine, higher substrate affinity (K m ) and superior 106 catalytic efficiency (k cat /K m ) (Supporting Information Table S1) [30] . We chose FjTAL 107 from Flavobacterium johnsoniae and SeSam8 from Saccharothrix espanaensis and 108 obtained the synthetic genes codon-optimized for expression in E. coli. In a first pass, 109 utilizing these two TALs in the same three plasmid expression system as used by 110
Rodrigues et al., and providing glucose as the only carbon source, we observed 111 accumulation of caffeic acid 72 h post induction (p. i.). The highest titers of caffeic acid 112 and p-coumaric acid are seen with the FjTAL enzyme (Figure 2A , strain s02). In a 113 parallel experiment, where 3 mM L-tyrosine was fed in addition to glucose, the final 114 caffeic acid titers were comparable among the three strains ( Figure 2B ). This indicates 115 that all enzymes are able to efficiently route L-tyrosine into the caffeic acid pathway at 116 high L-tyrosine concentrations, whereas FjTAL outperforms the other enzymes under 117 low L-tyrosine conditions and is therefore a strong candidate for this pathway. 118
Next, we sought to improve the efficiency of the second pathway step, the hydroxylation 119 of p-coumaric acid to caffeic acid catalyzed by CYP199A2 F185L NΔ7, by enhancing 120 the efficiency of the electron transfer step from the two redox partner proteins to 121 CYP199A2 F185L NΔ7. To achieve this goal, we tested three strategies: 1. the use of 122 alternative redox partners, 2. the tethering of the redox complex by creating genetic 123 fusions with high-affinity tethering domains, and 3. the supply of extra gene copies 124 coding for one of the redox partners. To facilitate cloning from here on in the study, we 125 use both multiple cloning sites of the pETDuet vector for the genes encoding redox 126 enzymes rather than the bicistronic pKVS45 vector (see Tables 1 and 2 proven to support substrate turnover, it remained unclear whether the assembly of the 135 trimeric complex and the respective redox potentials of the proteins supported optimal 136 electron transfer. Therefore, we decided to test the natural redox system (Pux/PuR) 137 alongside a well-characterized surrogate redox system (Pdx/PdR). We determined the 138 caffeic acid titers 72 h p. i. with supplementation of p-coumaric acid for three strains 139 expressing CYP199A2 F185L NΔ7 and one of the three respective redox systems 140
Pux/PdR (hybrid, s04), Pux/PuR (natural, s05), Pdx/PdR (surrogate, s06). We observed 141 the highest titers for the natural redox system (s05) and no turnover with the full 142 surrogate system composed of Pdx/PdR ( Figure 3A ). This suggests that the electron 143 transfer from ferredoxin to CYP199A2 F185L NΔ7 is severely impaired with the 144 surrogate ferredoxin Pdx, whereas the electron transfer from PdR to Pux in the hybrid 145 system appears to sufficiently support substrate turnover. The native redox complex 146
Pux/PuR, however, displays the highest catalytic power and a titer of 1.6 +/-0.32 mM 147 caffeic acid was observed which corresponds to 53% conversion of the fed p-coumaric 148 acid. These results indicate that the careful choice of redox system is crucial for this 149 pathway step. 150
With our second strategy, we sought to further improve these redox systems by 151 generating genetic fusions of the enzymes with the subunits of the heterotrimeric DNA 152 sliding clamp PCNA (Proliferating Cell Nuclear Antigen) of Sulfolobus solfataricus P2 153
[34]. This PCNA complex has been shown to tolerate the fusion of other genes to the '3 154 ends (C-termini) [35] of its three subunits, while maintaining their high binding affinity 155 towards each other: the PCNA1/PCNA2 dimer has a dissociation constant in the low 156 picomolar range and the PCNA1/PCNA2/PCNA3 trimer in the high nanomolar range 157
[34]. This fusion strategy has been shown to be highly efficient for the in vitro 158 reconstitution of Cytochrome P450 activity and was termed PUPPET by the inventors 159 (PCNA-utilized protein complex of P450 and its two electron transfer-related proteins) 160 [35] [36] [37] [38] [39] [40] . To our knowledge, this strategy hasn't been used in whole-cell catalysis to 161
date. Initially, we tested fusion proteins analogous to the previously described PUPPET 162 fusions with FdR fused to the C-terminus of PCNA domain 1, Fdx to PCNA2 and the 163 Cytochrome P450 to PCNA3 (tether design I, strains s07-s09; Figure 3B ). When feeding 164 3 mM p-coumaric acid, we observed higher titers of caffeic acid for all tethered redox 165 systems than compared to the respective free enzymes. The effect was more 166 pronounced with the hybrid and surrogate systems, where a 6-fold increase in titer was 167 observed for Pux/PdR (s07) and an 8-fold increase for Pdx/PdR (s09). Overall, the 168 highest titer was observed with the tethered version of Pux/PdR (s07, titer: 2.3 +/-0.07 169 mM). Next, we investigated whether these titers could be further improved by 170 generating a new arrangement of the fusion partners. Based on the published dissociation constants for the well-studied Cytochrome P450 CYP101A1 and its redox 172 partners [41, 42] , we assumed that the affinity of Fdx to FdR is about 100-fold higher 173 than the affinity of Fdx to the Cytochrome P450. We hypothesized that the high affinity 174
interaction between PCNA1 and PCNA2 might be even more beneficial to the low 175 affinity interaction between the Cytochrome P450 and Fdx than between Fdx and FdR. 176 Therefore, we generated a second set of fusion genes (tether design II), where 177 CYP199A2 F185L NΔ7 is fused to PCNA1, Fdx to PCNA2 and FdR to PCNA3, while 178 maintaining the linker arrangements that had previously been optimized for the 179 respective elements of the redox complex [39] (s 10-s12, Fig 3C) . With these alternative 180 tethering constructs, the highest final caffeic acid titers were obtained with the surrogate 181 Pdx/PdR redox system (s10, titer: 2.1 +/-0.35 mM), while the titers obtained with the 182 other redox systems were lower than in the previous experiments. This indicates that 183 the domain arrangements in the second tether design supports the weaker protein-184 protein interactions in the surrogate redox complex better than the other tether design, 185
whereas it disturbs catalysis with the two redox systems that already led to high titers 186 with free redox partners and tether design I. 187
Next, we tested the best redox partner constructs in the context of the full pathway with 188
FjTAL as the first pathway enzyme ( Figure 3D ). We observed the highest caffeic acid 189 titers with the untethered, natural redox partners (Pux/PuR, s15, titer: 0.14 +/-190 0.028 mM). Although strains s07, s08 and s12 had slightly outperformed s05 in the one- Figure 4A ). This indicates that the availability of Pux was 210 previously insufficient and that a higher expression level of this protein supports better 211 Cytochrome P450 performance. Despite the improvements in final caffeic acid titer, we 212 observed an accumulation of p-coumaric acid in early fermentation until 48 h p. i. and 213 then a sharp drop in titer until it is fully converted to caffeic acid at 96 h p. i. ( Figure 4B ). 214
This indicates that in early fermentation the first pathway step is still faster than the 215 acid is faster than the formation of the intermediate, or no additional p-coumaric acid is 217 formed. This could be caused by the lack of available L-tyrosine once the cultures reach 218 stationary phase, although we did not observe increased titers when spiking the cultures 219 with 3 mM L-tyrosine at 48 h p. i. (I Figure S1 ). Therefore, we are inclined to suggest 220 that the tyrosine ammonia lyase has lost its activity by that time. Potential causes could 221 be structural instability of the TAL enzyme or its inhibition by the intermediate as 222
described previously [27] . Overall, with the exchange of RgTAL for FjTAL and the 223 change of the redox system from Pux/PdR to Pux/PuR with an additional gene copy of 224 pux, we improved this recombinant pathway and were able to produce caffeic acid from 225 glucose without feeding L-tyrosine. The highest final titer after 96 h of fermentation was 226 47 mg/L, which is slightly higher than caffeic acid titers achieved with other recombinant 227 pathways without L-tyrosine supplementation [17, 19] . Furthermore, the improved 228 pathway is able to convert >50% of fed L-tyrosine to caffeic acid (SI Figure S1 pathway itself before moving into a microbial chassis with deregulated aromatic amino 243 acid production. In this study, we optimized the two-step conversion of L-tyrosine to 244 caffeic acid. Here it is important to ensure high efficiency of the second pathway step to 245 avoid accumulation of p-coumaric acid, which has been shown to severely inhibit the 246 activity of the first pathway enzyme, TAL [27] . The three strategies we tested focused 247 on the electron-donating redox partners rather than the Cytochrome P450 enzyme itself. 248
Previous in vitro studies of this particular Cytochrome P450 and others have shown that 249 the right choice of redox system, in particular the ferredoxin, is crucial for efficient 250 electron transfer and enzyme catalysis [29, 33] . As expected, we observed the highest 251 caffeic acid titers with the natural redox system composed of Pux and PuR in the one-252 step conversion with untethered redox partners. However, when we applied tethering 253 strategies to increase the affinity of the Cytochrome P450 and the redox partners 254 towards each other, we observed higher titers with the non-natural redox partners. 255
Tethering strategies have previously been applied to several Cytochrome P450 256 enzymes, both in vitro [35, 42, [48] [49] [50] [51] and in vivo [42, 48] . The in vitro studies showed 257 that tethered redox complexes are able to overcome the need to use an excess of redox 258 partners over the Cytochrome P450 enzyme, to compensate for low protein-protein 259 affinities (typically a five-to twenty-fold molar excess of ferredoxin is used in vitro). Since our strategy only doubled the gene dose of pux, it is very well possible that 280 rearranging the genes in the vector system to achieve higher protein levels of Pux 281 relative to the other enzymes could lead to even better results than described in this 282 study. Our optimization efforts of the second pathway step in combination with the use 283 of FjTAL for the first pathway step, enabled us to demonstrate the de novo production of 284 caffeic acid in an otherwise wild type E. coli background. FjTAL had previously been 285 seen to be beneficial for the production of p-coumaric acid and its derivatives in other 286 microbes [11, 54, 55], however, to our knowledge it has not been used in E. coli. It 287 appears that this enzyme allows for a more efficient routing of L-tyrosine into the caffeic 288 acid pathway than RgTAL at low L-tyrosine concentrations. Under high L-tyrosine 289 conditions, at levels that we would expect in tyrosine producer strains [56], our 290 fermentation strains expressing FjTAL achieve slightly higher caffeic acid titers than the 291 strains expressing RgTAL and lower titers of p-coumaric acid. This indicates that the 292 optimized pathway is more balanced so that less p-coumaric acid accumulates but 293 overall less L-tyrosine is converted into p-coumaric acid. To further improve these 294 results, it is necessary to investigate the stability and activity of the FjTAL enzyme over 295 time, since it appears to be inactive after 48h of fermentation. 296
Conclusions 297
In this study we established de novo synthesis of caffeic acid by expressing tyrosine 298 ammonia lyase from Flavobacterium johnsoniae and CYP199A2 F185L N 7 from 299
Rhodopseudomonas palustris with its redox partners palustrisredoxin and 300 palustrisredoxin reductase. We found that compared to earlier versions of this pathway, 301 changes made to the redox partners, namely the use of palustrisredoxin reductase 302 instead of putidaredoxin reductase and the duplication of the palustrisredoxin gene 303 dose, as well as the use of FjTAL instead of RgTAL, enhanced the pathway 304 performance under low L-tyrosine conditions as encountered in otherwise wild type E. 305 coli. Furthermore, we observed that applying a tethering strategy to the Cytochrome 306 P450-catalyzed pathway step based on the PUPPET system [35] increases caffeic acid 307 titers in strains expressing non-natural redox systems. This indicates that this strategy can be useful for pathways containing orphan bacterial Cytochromes P450. The 309 optimized caffeic acid pathway could now be transferred into a tyrosine-producer E. coli 310 strain for more in-depth characterization or process engineering. 311
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Competing interests 404
The authors declare that they have no competing interests. This study c25 pCDFduet::_PCNA3-CYP199A2 F185L NΔ7
This study c28 pETduet::6His-PCNA2-Pux_PCNA1-PdR (opt)
This study c50 pETduet::6His-Pux_PdR (opt)
This study c62 pETduet::6His-Pux_PuR
This study c63 pETduet::6His-PCNA2-Pux_PCNA1-PuR
This study c71 pRSFduet::6His-FjTAL
This study c72 pRSFduet::6His-SeSam8
This study c84 pCDFduet::6His-Pux_6His-CYP199A2F185L NΔ7
This study c86 pETduet::6His-Pdx_PdR (opt)
This study c88 pETduet::6His-PCNA2-Pdx_PCNA1-PdR(opt)
This study c96 pCDFduet::_PCNA1-GGS-CYP199A2 F185L NΔ7
This study c97 pETduet::6His-PCNA2-Pux_PCNA3- ( 
